These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 12041022)

  • 21. Neuropsychological and neuroimaging aspects of latent hepatic encephalopathy (LHE).
    O'Carroll R
    Alcohol Alcohol Suppl; 1993; 2():191-5. PubMed ID: 7748299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study.
    Amodio P; Campagna F; Olianas S; Iannizzi P; Mapelli D; Penzo M; Angeli P; Gatta A
    J Hepatol; 2008 Sep; 49(3):346-53. PubMed ID: 18602716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of brain evoked potentials in the detection of subclinical hepatic encephalopathy in cirrhotics].
    Ryu N; Gao W; Yan M
    No To Shinkei; 1997 Oct; 49(10):887-92. PubMed ID: 9368885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review article: the modern management of hepatic encephalopathy.
    Bajaj JS
    Aliment Pharmacol Ther; 2010 Mar; 31(5):537-47. PubMed ID: 20002027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and therapy of portosystemic encephalopathy].
    Weissenborn K
    Schweiz Rundsch Med Prax; 1994 Sep; 83(38):1059-64. PubMed ID: 7939069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological and neurophysiological evaluation in cirrhotic patients with minimal hepatic encephalopathy undergoing liver transplantation.
    Senzolo M; Amodio P; D'Aloiso MC; Fagiuoli S; Del Piccolo F; Canova D; Masier A; Bassanello M; Zanus G; Burra P
    Transplant Proc; 2005 Mar; 37(2):1104-7. PubMed ID: 15848636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive evoked response potentials in patients with liver cirrhosis without diagnosis of minimal or overt hepatic encephalopathy. A pilot study.
    Ciecko-Michalska I; Wojcik J; Wyczesany M; Binder M; Szewczyk J; Senderecka M; Dziedzic T; Slowik A; Mach T
    J Physiol Pharmacol; 2012 Jun; 63(3):271-6. PubMed ID: 22791641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Minimal hepatic encephalopathy: characteristics, diagnosis and clinical implications].
    Torre Delgadillo A; Guerrero-Hernández I; Uribe M
    Rev Gastroenterol Mex; 2006; 71(1):63-70. PubMed ID: 17061481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic encephalopathy.
    Córdoba J; Mínguez B
    Semin Liver Dis; 2008 Feb; 28(1):70-80. PubMed ID: 18293278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy?
    Quero Guillén JC; Groeneweg M; Jiménez Sáenz M; Schalm SW; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 2002 Sep; 94(9):544-57. PubMed ID: 12587235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening of subclinical hepatic encephalopathy.
    Groeneweg M; Moerland W; Quero JC; Hop WC; Krabbe PF; Schalm SW
    J Hepatol; 2000 May; 32(5):748-53. PubMed ID: 10845661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral changes in hepatic encephalopathy.
    Watanabe A
    J Gastroenterol Hepatol; 1998 Jul; 13(7):752-60. PubMed ID: 9715431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurophysiological assessment of early hepatic encephalopathy.
    Weissenborn K; Scholz M; Hinrichs H; Wiltfang J; Schmidt FW; Künkel H
    Electroencephalogr Clin Neurophysiol; 1990 Apr; 75(4):289-95. PubMed ID: 1691077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic encephalopathy.
    Lockwood AH
    Neurol Clin; 2002 Feb; 20(1):241-6, vii. PubMed ID: 11754309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of abnormal psychometric tests and critical flicker frequency after clinical recovery of overt hepatic encephalopathy.
    Sharma P; Sharma BC; Sarin SK
    Neurol India; 2010; 58(2):220-4. PubMed ID: 20508339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is hyperammonemia really the true cause of altered neuropsychology, brain MR spectroscopy and magnetization transfer after an oral amino acid load in cirrhosis?
    Riggio O; Efrati C; Masini A; Angeloni S; Merli M
    Hepatology; 2003 Sep; 38(3):777; author reply 778. PubMed ID: 12939607
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diagnosis of subclinical hepatic encephalopathy: a parallel and comparative study between the evoked potentials and the performance psychometric tests].
    Zhu Q; Yang YL; Wang MJ
    Zhonghua Nei Ke Za Zhi; 1993 Oct; 32(10):676-8. PubMed ID: 8156838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Methods of Testing and Brain Imaging in Hepatic Encephalopathy: A Review.
    Edula RG; Pyrsopoulos NT
    Clin Liver Dis; 2015 Aug; 19(3):449-59. PubMed ID: 26195200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: search for a rational approach.
    Sood GK; Sarin SK; Mahaptra J; Broor SL
    Am J Gastroenterol; 1989 Feb; 84(2):156-9. PubMed ID: 2916526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.